In the last three months, 8 analysts have published ratings on Ovintiv (NYSE:OVV), offering a diverse range of perspectives from bullish to bearish.
The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 1 | 6 | 1 | 0 | 0 |
| Last 30D | 0 | 1 | 0 | 0 | 0 |
| 1M Ago | 0 | 1 | 0 | 0 | 0 |
| 2M Ago | 1 | 0 | 1 | 0 | 0 |
| 3M Ago | 0 | 4 | 0 | 0 | 0 |
Analysts have recently evaluated Ovintiv and provided 12-month price targets. The average target is $51.25, accompanied by a high estimate of $57.00 and a low estimate of $47.00. This current average has decreased by 0.72% from the previous average price target of $51.62.
Deciphering Analyst Ratings: An In-Depth Analysis
An in-depth analysis of recent analyst actions unveils how financial experts perceive Ovintiv. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
| Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
|---|---|---|---|---|---|
| Arun Jayaram | JP Morgan | Lowers | Overweight | $47.00 | $50.00 |
| Nitin Kumar | Mizuho | Lowers | Outperform | $50.00 | $58.00 |
| Josh Silverstein | UBS | Raises | Buy | $52.00 | $51.00 |
| Devin McDermott | Morgan Stanley | Lowers | Equal-Weight | $48.00 | $52.00 |
| Arun Jayaram | JP Morgan | Raises | Overweight | $50.00 | $46.00 |
| Betty Jiang | Barclays | Raises | Overweight | $57.00 | $55.00 |
| Jason Bouvier | Scotiabank | Raises | Sector Outperform | $51.00 | $48.00 |
| Betty Jiang | Barclays | Raises | Overweight | $55.00 | $53.00 |
Key Insights:
- Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Ovintiv. This insight gives a snapshot of analysts' perspectives on the current state of the company.
- Rating: Offering a comprehensive view, analysts assess stocks qualitatively, spanning from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Ovintiv compared to the broader market.
- Price Targets: Delving into movements, analysts provide estimates for the future value of Ovintiv's stock. This analysis reveals shifts in analysts' expectations over time.
Navigating through these analyst evaluations alongside other financial indicators can contribute to a holistic understanding of Ovintiv's market standing. Stay informed and make data-driven decisions with our Ratings Table.
Stay up to date on Ovintiv analyst ratings.
All You Need to Know About Ovintiv
Ovintiv Inc is a North American oil and natural gas exploration and production company that is focused on developing its multi-basin portfolio of high-quality assets located in the United States and Canada. Its operations also include the marketing of oil, NGLs and natural gas. The company has two operating segments: USA Operations, and Canadian Operations. The USA Operations include the exploration for, development of, and production and marketing of oil, NGLs, natural gas and other related activities within the United States. The Canadian Operations include the exploration for, development of, and production and marketing of oil, NGLs, natural gas and other related activities within Canada.
Breaking Down Ovintiv's Financial Performance
Market Capitalization Analysis: The company exhibits a lower market capitalization profile, positioning itself below industry averages. This suggests a smaller scale relative to peers.
Positive Revenue Trend: Examining Ovintiv's financials over 3M reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 1.31% as of 30 June, 2025, showcasing a substantial increase in top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Energy sector.
Net Margin: Ovintiv's net margin lags behind industry averages, suggesting challenges in maintaining strong profitability. With a net margin of 13.24%, the company may face hurdles in effective cost management.
Return on Equity (ROE): Ovintiv's ROE is below industry averages, indicating potential challenges in efficiently utilizing equity capital. With an ROE of 3.0%, the company may face hurdles in achieving optimal financial returns.
Return on Assets (ROA): Ovintiv's ROA falls below industry averages, indicating challenges in efficiently utilizing assets. With an ROA of 1.56%, the company may face hurdles in generating optimal returns from its assets.
Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 0.64.
Understanding the Relevance of Analyst Ratings
Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
If you want to keep track of which analysts are outperforming others, you can view updated analyst ratings along withanalyst success scores in Benzinga Pro.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. Click here for urgent details.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
